Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
FMC-376 by Frontier Medicines for Non-Small Cell Lung Cancer: Likelihood of Approval
FMC-376 is under clinical development by Frontier Medicines and currently in Phase II for Non-Small Cell Lung Cancer. According to...
FMC-376 by Frontier Medicines for Metastatic Colorectal Cancer: Likelihood of Approval
FMC-376 is under clinical development by Frontier Medicines and currently in Phase II for Metastatic Colorectal Cancer. According to GlobalData,...
FMC-376 by Frontier Medicines for Metastatic Pancreatic Cancer: Likelihood of Approval
FMC-376 is under clinical development by Frontier Medicines and currently in Phase II for Metastatic Pancreatic Cancer. According to GlobalData,...
FMC-376 by Frontier Medicines for Solid Tumor: Likelihood of Approval
FMC-376 is under clinical development by Frontier Medicines and currently in Phase II for Solid Tumor. According to GlobalData, Phase...